Sulphilimine cross-links in Goodpasture's disease

Clinical and Experimental Immunology

Volumn 164, Issue SUPPL. 1, 2011, Pages 4-6

  Vanacore, R ^a   Pedchenko, V ^a   Bhave, G ^a   Hudson, B G ^a,b,c  

^a Department of Medicine   (United States)

^b Department of Pathology ^*  (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoantigen; Goodpasture disease; Sulphilimine cross links

Indexed keywords

AUTOANTIGEN; EPITOPE; IMINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SULPHILIMINE; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHEMICAL BOND; CROSS LINKING; GOODPASTURE SYNDROME; HUMAN; IMMUNOPATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN STRUCTURE; T LYMPHOCYTE;

ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; AUTOANTIGENS; COLLAGEN TYPE IV; CROSS-LINKING REAGENTS; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; HUMANS; PROTEIN CONFORMATION;

EID: 79953144070     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04356.x     Document Type: Article

References (10)

1. Pedchenko V, Bondar O, Fogo AB etal. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med 2010; 363:343-54.
2. Sundaramoorthy M, Meiyappan M, Todd P, Hudson BG. Crystal structure of NC1 domains. Structural basis for type IV collagen assembly in basement membranes. J Biol Chem 2002; 277:31142-53.
3. Vanacore RM, Ham AJ, Cartailler JP etal. A role for collagen IV cross-links in conferring immune privilege to the Goodpasture autoantigen: structural basis for the crypticity of B cell epitopes. J Biol Chem 2008; 283:22737-48.
4. Vanacore R, Ham AJ, Voehler M etal. A sulfilimine bond identified in collagen IV. Science 2009; 325:1230-4.
5. David M, Borza DB, Leinonen A, Belmont JM, Hudson BG. Hydrophobic amino acid residues are critical for the immunodominant epitope of the Goodpasture autoantigen. A molecular basis for the cryptic nature of the epitope. J Biol Chem 2001; 276:6370-7.
6. Borza D-B, Bondar O, Todd P etal. Quaternary organization of the Goodpasture autoantigen, the alpha 3(IV) collagen chain. Sequestration of two cryptic autoepitopes by intraprotomer interactions with the α4 and α5 NC1 domains. J Biol Chem 2002; 277:40075-83.
7. Wieslander J, Langeveld J, Butkowski R, Jodlowski M, Noelken M, Hudson BG. Physical and immunochemical studies of the globular domain of type IV collagen. Cryptic properties of the Goodpasture antigen. J Biol Chem 1985; 260:8564-70.
8. Borza DB, Bondar O, Colon S etal. Goodpasture autoantibodies unmask cryptic epitopes by selectively dissociating autoantigen complexes lacking structural reinforcement: novel mechanism for immune privilege and autoimmune pathogenesis. J Biol Chem 2005; 280:27147-54.
9. Phelps RG, Rees AJ. The HLA complex in Goodpasture's disease: a model for analyzing susceptibility to autoimmunity. Kidney Int 1999; 56:1638-53.
10. Zou J, Henderson L, Thomas V, Swan P, Turner AN, Phelps RG. Presentation of the Goodpasture autoantigen requires proteolytic unlocking steps that destroy prominent T cell epitopes. J Am Soc Nephrol 2007; 18:771-9.